3
Announcements
Trials
Browse
Landscape
Status
Completed
3
Unknown
2
Sponsor Class
INDUSTRY
2
Study Type
Observational
2
Interventional
1
Sponsor
Conditions
Breast Neoplasms
566
Neoplasms
463
Lung Neoplasms
295
Colorectal Neoplasms
291
Carcinoma, Non-Small-Cell Lung
213
Stomach Neoplasms
209
Carcinoma, Hepatocellular
201
Prostatic Neoplasms
181
Pancreatic Neoplasms
151
Ovarian Neoplasms
138
Uterine Cervical Neoplasms
126
Colonic Neoplasms
121
Rectal Neoplasms
113
Urinary Bladder Neoplasms
96
Neoplasm Metastasis
95
Esophageal Neoplasms
85
Endometrial Neoplasms
83
Head and Neck Neoplasms
80
Precursor Cell Lymphoblastic Leukemia-Lymphoma
79
Leukemia, Myeloid, Acute
78
Recurrence
68
Brain Neoplasms
68
Melanoma
66
Disease
64
Multiple Myeloma
59
Liver Neoplasms
58
Lymphoma
57
Glioma
56
Polycystic Ovary Syndrome
53
Squamous Cell Carcinoma of Head and Neck
51
Interventions
Nasal Sprays
2
Fentanyl
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Unknown
×
Observational
×
Breakthrough Cancer Pain
×
Clear all
NCT01693328
2014-01-15
Qualipec
Archimedes Development Ltd
Unknown
300 enrolled
NCT01698645
2013-07-11
Qualipec
Archimedes Development Ltd
Unknown
150 enrolled